Investigators were seeking clarification on optimal sequencing of the immune checkpoint inhibitor atezolizumab following ...

The approval of Yesintek (ustekinumab-kfce), the sixth biosimilar to reference Stelara, will be used to treat patients with ...

The US can learn from what other countries are doing well to implement the best programs to improve patient access to care, ...

Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...

Matias Sanchez, MD, assistant professor in the Department of Medicine at the University of Illinois Chicago, discussed recent advancements in multiple myeloma treatment, including the potential of ...

COVID-19 vaccination significantly reduced anxiety and depression in patients with idiopathic pulmonary fibrosis (IPF), ...

Deuruxolitinib showed significant efficacy and safety in hair regrowth stimulation among adult patients with alopecia areata, ...

Phase 2 data show about half of patients with high-risk or secondary acute myeloid leukemia achieved a complete response or ...

The findings show that increases in serum glial fibrillary acidic protein throughout B-cell depletion therapy are associated ...

A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

The 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report highlighted climate change, cardiovascular risk ...

The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with ...